41
Views
0
CrossRef citations to date
0
Altmetric
Orignal Articles

Lack of Chemopreventive Activity of Agaricus blazei Mushroom on the Development of 1,2-Dimethylhydrazine-Induced Colonic Aberrant Crypt Foci in Rats

, , , , &
Pages 768-775 | Received 22 Aug 2007, Accepted 07 May 2008, Published online: 13 Nov 2008
 

Abstract

Chemopreventive and immunomodulatory potential of methanolic (MET) and dichloromethanic (DCl) extracts of Agaricus blazei mushroom were investigated in the postinitiation stage of colon carcinogenesis in male Wistar rats. Animals were initiated with 1,2-dimethylhydrazine (DMH) and treated i.g. with DCl or MET extracts. After 9 wk, animals were sacrificed for evaluation of aberrant crypt foci (ACF) development, crypt cellular proliferation, preneoplastic liver lesions (GST-P), proliferative response of spleen cells to mitogen, and natural killer activity. Administration of DCl extracts did not suppress DMH-induced colonic ACF nor did it affect the crypt multiplicity, but the highest dose of MET significantly reduced the development of preneoplastic lesions in the colon and liver. Lymphoproliferative response was slightly decreased in the initiated control group, which was restored by treatment with MET. No toxicity from DCl and MET extracts was observed (groups MET and DCl).

ACKNOWLEDGMENTS

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP-98/07726-5R), Brazil. G. Ribeiro Santos and F. C. Lopes were recipients of fellowships from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and A. L. T. Spinardi-Barbisan from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

Notes

a n = 12. Abbreviations are as follows: ACF, aberrant crypt foci; DMH, 1,2-dimethylhydrazine; GST-P, gluthatione S-transferase P; ACs, aberrant crypts; DCl, dichloromethanic;

b Liver minifoci positive for GST-P.

c Different from DMH group (P < 0.05).

d Different from all other groups (P < 0.02).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.